Idenix Pharmaceuticals (IDIX)

[keitern]

I respecfully disagree, but it is history now.

This says exactly what IDIX did, very clearly. Reuters version was quite different IMO.

"Idenix will discontinue all development, manufacturing and commercial activities for Tyzeka/Sebivo. Novartis will continue these activities and have full responsibility for ongoing and future clinical trials and regulatory filings related to Tyzeka/Sebivo. Additionally, Idenix will receive a royalty on worldwide product sales. "